BODENSTEDT MATTHIAS (Chief Financial Officer) reported 2 transactions at MOONLAKE IMMUNOTHERAPEUTICS
Review the transaction codes below to understand the nature of each event.
Filed: 12/22/2025ACC: 0001213900-25-124519
Officer· Chief Financial Officer
Since Apr 2022
-8.75K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
294.47K acquired · 303.23K disposed
Non-Derivative Transactions2
Class A ordinary shares, par value $0.0001 per share
Direct
Shares
+294.47K
Price / share
—
Trade value
—
% of position
46.9%
12/19/2025
627.54K→922.01K
Class C ordinary shares, par value $0.0001 per share
Direct
Shares
−294.47K
Price / share
—
Trade value
—
% of position
New position
12/19/2025
294.47K→0.00
Total
Net shares
+0.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A ordinary shares, par value $0.0001 per share Direct | 12/19/2025 | C · Conversion | +294.47K | — | — | 46.9% | 627.54K | 922.01K |
| Class C ordinary shares, par value $0.0001 per share Direct | 12/19/2025 | D · Disposition | −294.47K | — | — | New position | 294.47K | 0.00 |
| Total | +0.00 | $0.00 | ||||||
Derivative Transactions1
Common shares, par value CHF 0.10 per share, of MoonLake AG
Direct
Converts to
Class A ordinary shares, par value $0.0001 per share
294.47K shares
Shares
−8.75K
Strike price
Held after
0.00
Exercisable
—
12/19/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common shares, par value CHF 0.10 per share, of MoonLake AG Direct | Class A ordinary shares, par value $0.0001 per share294.47K shares | 12/19/2025 | C · Conversion | −8.75K | — | 0.00 |